<DOC>
	<DOCNO>NCT01211314</DOCNO>
	<brief_summary>Treatment control hypertension still insufficient . About 50 % patient remain uncontrolled . Lack compliance discontinuation drug treatment important reason achieve blood pressure . Several study show use fix combination improve compliance significantly , reduce number pill 's intake . This study assess antihypertensive efficacy Vasodip-Combo 20® [ enalapril 20 mg + lercanidipine 10 mg ] fixed combination drug uncontrolled antihypertensive patient .</brief_summary>
	<brief_title>Antihypertensive Efficacy Fixed Combination Drug</brief_title>
	<detailed_description>This single centre observational uncontrolled prospective study , Hypertensive patient either treatment naïve uncontrolled current therapy [ one two drug ] meet inclusion exclusion criterion , assign Vasodip-Combo 20 unique drug treatment . The treatment continue additional 4 week . Office blood pressure perform physician visit . 24 h. ambulatory blood pressure measurement [ ABPM ] blood sample electrolytes , creatinine urea take base line visit week 4 . Efficacy define term therapeutic goal express target blood pressure accord World Health Organization European society Hypertension [ office blood pressure ambulatory blood pressure measurement ] criterion : Office Blood Pressure : Diastolic blood pressure ≤ 90 mmHg Systolic blood pressure ≤ 140 mmHg non-diabetics Diastolic Blood Pressure ≤ 80 mmHg Systolic Blood Pressure ≤ 130 mmHg diabetic , respectively . 24 h Ambulatory Blood Pressure Measurements : 224 Hour : Diastolic Blood Pressure≤ 80 mmHg Systolic Blood Pressure ≤ 130 mmHg , Awake time : Diastolic Blood Pressure ≤ 85 mmHg , Systolic Blood Pressure ≤ 135 mmHg Asleep Time : Diastolic Blood Pressure ≤70 mmHg , Systolic Blood Pressure ≤ 70 mmHg . Effectiveness Safety also evaluate take consideration patient compliance Safety assessment : Safety assess mean ( S ) Adverse effect report .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Lercanidipine</mesh_term>
	<criteria>1 . Essential hypertension visit 1 defined office blood pressure &lt; 140/90 mmHg 24 h ABPM &gt; 130/80 mmHg day time blood pressure ( extracted 24h ABPM ) &gt; 135/85 mmHg 2 . Male female 3 . Age 1880 4 . Every patient medical opinion treat physician eligible Vasodip Combo 20 treatment . 5 . Willing sign inform consent 1 . Use 2 anti hypertensive medication visit 1 ( fix combination consider two drug ) 2 . Mean 24 h ABPM value 180/100 mmHg 3 . Pregnant woman 4 . Women potential age pregnancy . 5 . Suspected secondary hypertension ( investigator decision ) 6 . Uncontrolled Diabetes Mellitus ( investigator decision ) 7 . Any following last six month : Myocardial Infarction , Stroke , Coronary bypass surgery , Percutaneous coronariography balloon dilation and/or stent insertion 8 . Congestive Heart Failure require pharmacological treatment 9 . Renal Failure , define serum creatinine equal great 1.5 mg % [ confirm twice ] hyperkalemia define serum potassium equal great 5 meq/l [ confirm twice ] 10 . Malignancy require Chemotherapy last 3 year . 11 . Any medical none medical condition eye investigator allow patient complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>Fixed combination</keyword>
	<keyword>lercanidipine</keyword>
	<keyword>enalapril</keyword>
	<keyword>Blood Pressure Monitoring , Ambulatory</keyword>
</DOC>